ArticleActa pharmacologica Sinica2025

Humanized dual-targeting antibody-drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity.

Minghai Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.